Stage IV NSCLC with long-term progression-free survival by erlotinib treatment

Date 08 July 2015
Event ESMO Preceptorship on NSCLC 2015
Session Session 5 - case discussion
Topics Anti-Cancer Agents & Biologic Therapy
Non-Small-Cell Lung Cancer, Metastatic
Presenter Milan Paul Kubelac
Authors M.P. Kubelac
  • 400367 - Cluj Napoca/AF